For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective, stable, and patient-friendly medications. For the pharmaceutical industry ...

Drug formulation is becoming increasingly complex. Poorly soluble APIs, personalized medicines, and advanced oral dosage forms require production methods that are scalable, reproducible, and precise.

Dave Miller, PhD, explains how early formulation planning, novel platforms, and tailored approaches secure long-term protection against generics. In this final part of our 5-part interview series on ...

In the quest to develop safe and effective medicines, pharmaceutical companies rely on the precise combination of active pharmaceutical ingredients (APIs) and excipients. These crucial components play ...

This interview addresses the challenges and complexities of developing and manufacturing controlled-release drug formulations. Could you introduce yourself and your expertise in drug development and ...

Highly potent but poorly water-soluble drug (PWSD) candidates are common outcomes of contemporary drug discovery programmes. These lipophilic compounds often exhibit poor systemic exposure following ...

AI-driven robotics platform reduces drug formulation development time from years to months SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for ...

Wu Xiaohui of Wanhuida Intellectual Property examines how a recent CNIPA decision reinforces the need for a holistic inventive step assessment when evaluating pharmaceutical combination formulations ...

The global oral solid dosage pharmaceutical formulation industry is poised for remarkable growth, with a projected Compound Annual Growth Rate (CAGR) of 6.4% from 2022 to 2032. According to the latest ...